statistiche ricercatore

Continente	#
EU - Europa	3.182
AS - Asia	465
NA - Nord America	436
SA - Sud America	56
Continente sconosciuto - Info sul continente non disponibili	41
AF - Africa	11
Totale	4.191

Nazione	#
IT - Italia	3.030
US - Stati Uniti d'America	421
SG - Singapore	173
CN - Cina	129
BR - Brasile	43
BD - Bangladesh	37
VN - Vietnam	37
DE - Germania	25
NL - Olanda	21
FR - Francia	20
FI - Finlandia	17
SE - Svezia	16
AT - Austria	14
IN - India	14
KR - Corea	13
GB - Regno Unito	12
HK - Hong Kong	11
IQ - Iraq	9
CA - Canada	8
TR - Turchia	8
AR - Argentina	6
JP - Giappone	6
CH - Svizzera	4
IE - Irlanda	4
MX - Messico	4
PK - Pakistan	4
PT - Portogallo	4
CO - Colombia	3
GH - Ghana	3
ID - Indonesia	3
IL - Israele	3
MA - Marocco	3
PH - Filippine	3
SA - Arabia Saudita	3
ZA - Sudafrica	3
EC - Ecuador	2
ES - Italia	2
HU - Ungheria	2
JO - Giordania	2
LV - Lettonia	2
MO - Macao, regione amministrativa speciale della Cina	2
PL - Polonia	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AO - Angola	1
AZ - Azerbaigian	1
CZ - Repubblica Ceca	1
EE - Estonia	1
GT - Guatemala	1
JM - Giamaica	1
KG - Kirghizistan	1
LB - Libano	1
NO - Norvegia	1
NP - Nepal	1
RO - Romania	1
RU - Federazione Russa	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UA - Ucraina	1
UY - Uruguay	1
VE - Venezuela	1
Totale	4.150

Nome	#
Identification of new benzofuran derivatives as STING agonists with broad-spectrum antiviral activity	828
New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors	766
Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action	706
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination	635
Unlocking STING as a Therapeutic Antiviral Strategy	463
Exploring antiviral strategies: From innate immunity modulation to viral proteins targeting	213
The efficiency of high-throughput screening (HTS) and in-silico data analysis during medical emergencies: Identification of effective antiviral 3CLpro inhibitors	177
Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New Invalidation Pipeline and Identified a True Noncovalent Inhibitor Against Papain-like Protease from SARS-CoV-2	151
Dual-Site Inhibition of SARS-CoV2 RNA-Dependent RNA Polymerase by Small Molecules Able to Block Viral Replication Identified through a Computer-Aided Drug Discovery Approach	131
Identifying potential allosteric inhibitors of ZIKV NS3pro through a combined computational and biochemical approach	81
Identification of Nsp15 inhibitors restoring interferon-dependent antiviral activity against SARS-CoV-2	40
Totale	4.191

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	172	0	0	0	0	0	0	0	0	17	76	62	17
2023/2024	686	33	30	68	43	62	118	65	62	13	29	57	106
2024/2025	2.135	363	816	202	233	75	100	131	21	64	41	31	58
2025/2026	1.109	72	30	113	102	85	57	203	86	87	101	115	58
2026/2027	89	53	36	0	0	0	0	0	0	0	0	0	0
Totale													4.191

UNICA IRIS Institutional Research Information System